Lodestone Biomedical
Lebanon, US · Founded 2015 · Delaware corporation
Lodestone Biomedical develops biosensing and monitoring tools for the tumor microenvironment in preclinical cancer research models, enabling detection of immune response during early-stage drug discovery. Its research-use-only products and services serve drug development researchers conducting preclinical studies.
Founders & leadership
Lodestone Biomedical was founded in 2015 by Solomon Diamond.
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 4 rounds · 2017–2025
▶$75KraisedJul 2025 · 1 investors · BiotechnologyRule 506(b)
- Solomon DiamondExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $75K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$450KraisedDec 2021 · 6 investors · BiotechnologyRule 506(b)
- Solomon DiamondExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $450K
- First sale
- Dec 2021
- Incorporated
- Limited Liability Company, New Hampshire
- Federal exemptions
- 06b
▶$110KraisedApr 2020 · 3 investors · BiotechnologyRule 506(b)
- Solomon DiamondExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $110K
- Minimum investment
- $5K
- First sale
- Mar 2020
- Incorporated
- Limited Liability Company, New Hampshire, 2015
- Federal exemptions
- 06b
▶$550KraisedJul 2017 · 7 investors · BiotechnologyRule 506(b)
- Solomon DiamondExecutive Officer, Director
- Lidia ValdesExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $550K
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- Jul 2017
- Incorporated
- Limited Liability Company, New Hampshire, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $400K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Lodestone Biomedical do?
- Lodestone Biomedical develops biosensing and monitoring tools for the tumor microenvironment in preclinical cancer research models, enabling detection of immune response during early-stage drug discovery. Its research-use-only products and services serve drug development researchers conducting preclinical studies.
- Who founded Lodestone Biomedical?
- Lodestone Biomedical was founded by Solomon Diamond in 2015.
- How much funding has Lodestone Biomedical raised?
- Lodestone Biomedical has disclosed $1.2M raised across 4 rounds.
- Where is Lodestone Biomedical headquartered?
- Lodestone Biomedical is headquartered in Lebanon, US.